Logo

People in the News: James Weissman

Jan 05, 2012
Premium

Dicerna Pharmaceuticals has named James Weissman as its new chief business officer.

In this role, he will be responsible for corporate development, strategy, and other operational functions, the company said.

Weissman was previously vice president of business development at drug developer MannKind.

Filed under

Gene Silencing/Gene Editing
RNAi
Dicerna
Breaking News
The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.